Similar articles for PMID: 28694503

Year	Number of Results
1995	1
1998	2
1999	2
2000	1
2001	1
2002	2
2003	1
2006	1
2007	1
2010	4
2013	4
2014	4
2015	19
2016	19
2017	19
2018	8
2019	5
2020	3
2021	4
2024	0

1

CD44v8-10 as a potential theranostic biomarker for targeting disseminated cancer cells in advanced gastric cancer.

Choi ES, Kim H, Kim HP, Choi Y, Goh SH. Choi ES, et al. Sci Rep. 2017 Jul 10;7(1):4930. doi: 10.1038/s41598-017-05247-7. Sci Rep. 2017. PMID: 28694503 Free PMC article.

2

Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer.

Hagiwara M, Kikuchi E, Tanaka N, Kosaka T, Mikami S, Saya H, Oya M. Hagiwara M, et al. BMC Cancer. 2018 Jan 31;18(1):113. doi: 10.1186/s12885-018-3988-3. BMC Cancer. 2018. PMID: 29385995 Free PMC article.

3

Expression of CD44 variant exons 8-10 in gastric cancer.

Yamaguchi A, Saito M, Gio T, Iida A, Takeuchi K, Hirose K, Nakagawara G, Urano T, Furukawa K, Shiku H. Yamaguchi A, et al. Jpn J Cancer Res. 1995 Dec;86(12):1166-71. doi: 10.1111/j.1349-7006.1995.tb03310.x. Jpn J Cancer Res. 1995. PMID: 8636005 Free PMC article.

4

Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance.

Xu YY, Guo M, Yang LQ, Zhou F, Yu C, Wang A, Pang TH, Wu HY, Zou XP, Zhang WJ, Wang L, Xu GF, Huang Q. Xu YY, et al. Oncotarget. 2017 Jul 11;8(28):45848-45861. doi: 10.18632/oncotarget.17435. Oncotarget. 2017. PMID: 28507278 Free PMC article.

5

CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis.

Sosulski A, Horn H, Zhang L, Coletti C, Vathipadiekal V, Castro CM, Birrer MJ, Nagano O, Saya H, Lage K, Donahoe PK, Pépin D. Sosulski A, et al. PLoS One. 2016 Jun 2;11(6):e0156595. doi: 10.1371/journal.pone.0156595. eCollection 2016. PLoS One. 2016. PMID: 27253518 Free PMC article.

6

CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation.

Zhang P, Feng S, Liu G, Wang H, Fu A, Zhu H, Ren Q, Wang B, Xu X, Bai H, Dong C. Zhang P, et al. Oncogene. 2016 Sep 22;35(38):5056-5069. doi: 10.1038/onc.2016.67. Epub 2016 Apr 4. Oncogene. 2016. PMID: 27041584 Free PMC article.

7

Impact of Truncated O-glycans in Gastric-Cancer-Associated CD44v9 Detection.

Moreira IB, Pinto F, Gomes C, Campos D, Reis CA. Moreira IB, et al. Cells. 2020 Jan 21;9(2):264. doi: 10.3390/cells9020264. Cells. 2020. PMID: 31973075 Free PMC article.

8

CD44v8-10 is a cancer-specific marker for gastric cancer stem cells.

Lau WM, Teng E, Chong HS, Lopez KA, Tay AY, Salto-Tellez M, Shabbir A, So JB, Chan SL. Lau WM, et al. Cancer Res. 2014 May 1;74(9):2630-41. doi: 10.1158/0008-5472.CAN-13-2309. Epub 2014 Mar 11. Cancer Res. 2014. PMID: 24618343

9

A CD44-specific peptide, RP-1, exhibits capacities of assisting diagnosis and predicting prognosis of gastric cancer.

Li W, Jia H, Wang J, Guan H, Li Y, Zhang D, Tang Y, Wang TD, Lu S. Li W, et al. Oncotarget. 2017 May 2;8(18):30063-30076. doi: 10.18632/oncotarget.16275. Oncotarget. 2017. PMID: 28415792 Free PMC article.

10

CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer.

Go SI, Ko GH, Lee WS, Kim RB, Lee JH, Jeong SH, Lee YJ, Hong SC, Ha WS. Go SI, et al. Cancer Res Treat. 2016 Jan;48(1):142-52. doi: 10.4143/crt.2014.227. Epub 2015 Mar 17. Cancer Res Treat. 2016. PMID: 25779358 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

90 results

Results by year